Clinical Trials Logo

Hypoglycemia in Newborn Infants clinical trials

View clinical trials related to Hypoglycemia in Newborn Infants.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04353713 Recruiting - Clinical trials for Hypoglycemia in Newborn Infants

Gel for Early Hypoglycaemia Prevention in Preterm Infants

GEHPPI
Start date: November 5, 2020
Phase: N/A
Study type: Interventional

The GEHPPI study is a multicentre placebo controlled randomized controlled trial that aims to prevent early hypoglycaemia in preterm newborns born at ≤32 week's gestation. To do this we will prophylactically administer to these newborns either a small amount of dextrose 40% gel early as possible after birth via the buccal route in the delivery room or a placebo. We hope this dextrose gel will prevent hypoglycemia occurring during the time period needed for the newborns to be transported to the neonatal unit where they will have their venous access inserted. This trial aims to demonstrate that administering dextrose gel via the buccal route is a simple and rapid method of preventing early hypoglycaemia in this vulnerable patient group. This trial aims to show that giving dextrose gel via the buccal route is simple and feasible in this premature population. This trial aims to reduce the need for rescue intravenous dextrose (2ml/kg dextrose 10%) in those babies who are hypoglycaemic at the time of obtaining intravenous access.